Top Story
February 13, 2021
KARACHI: The registration board of Drug Regulatory Authority of Pakistan (DRAP) on Friday allowed emergency use of single-dose of Chinese Convidicea Vaccine (Ad5-nCoV) for COVID-19, developed by Chinese biopharmaceutical company CanSino Biologicals Inc., officials told ‘The News’.
Special Assistant to the Prime Minister (SAPM) on Health, Dr Faisal Sultan, also confirmed that the drug regulator has approved the emergency use of Ad5-nCoV in Pakistan on the recommendations of an experts committee, which had been constituted to assess the safety and efficacy of the vaccine, responsible to decide, whether the vaccine should be administered to people or not. The officials said the registration board of the DRAP has shown a positive nod to the manufacturer of coronavirus vaccine, after the committee comprising six infectious diseases experts, including pathologists and others, assessed the results and data submitted by the company and recommended for allo
I represent a community of children who suffer from a group of rare diseases collectively called lysosomal storage disorders . These genetic disorders are mostly seen in children from consanguineous.
Imran Khan, Xi Jinping
Recently, China has given approval to the CanSinoBio coronavirus vaccine, making it the second Chinese vaccine to receive approval by the CCP. The Pakistani Health Minister Faisal Sultan reported yesterday i.e. February 12 reported that the Drug Regulatory Authority of Pakistan has also given its approval for the vaccine.
The Chinese developed Sinopharm coronavirus vaccine, having been tested for effectiveness and safety, had also been approved by Pakistan in January for emergency use. Pakistan just recently begun its vaccination programme on February 3, having received vaccines free of cost from China.
Drug Regulatory Authority of Pakistan (Drap) had already approved three other Corornavirus vaccines for use in Pakistan, China’s Sinopharm, Oxford University-AstraZeneca vaccine and Russia’s Sputnik-V.